Original paper
Re: Wells et al.: Aflibercept, Bevacizumab, or Ranibizumab for diabetic macular edema: two year results from a comparative effectiveness randomized clinical trial ( Ophthalmology . 2016;123:1351-1359)
Abstract
The Diabetic Retinopathy Clinical Research Network (DRCR.net) has made useful observations regarding diabetic retinopathy, including their most recent manuscript.1Wells J.A. Glassman M.S. Ayala A.R. et al.Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.Ophthalmology. 2016; 123: 1351-1359Abstract Full Text Full Text PDF PubMed Scopus (579) Google Scholar However, I have questions about their classification of and conclusions...
Paper Details
Title
Re: Wells et al.: Aflibercept, Bevacizumab, or Ranibizumab for diabetic macular edema: two year results from a comparative effectiveness randomized clinical trial ( Ophthalmology . 2016;123:1351-1359)
Published Date
Apr 1, 2017
Journal
Volume
124
Issue
4
Pages
e37 - e38
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History